What is Castle Biosciences's EV / sales?

Castle Biosciences (CSTL) reported EV / sales of 2.1× in Q1 2026.

How has Castle Biosciences's EV / sales changed year-over-year?

Castle Biosciences's EV / sales increased by 41.5% year-over-year, from 1.5× to 2.1×.

What is the long-term trend for Castle Biosciences's EV / sales?

Over 4 years (2021 to 2025), Castle Biosciences's EV / sales has grown at a -21.6% compound annual growth rate (CAGR), from 8.1× to 3.1×.

What does EV / sales mean?

Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.

Castle Biosciences CSTL EV / sales

EV / sales at other companies

Labcorp HoldingsLH

2×+0.1×

VeracyteVCYT

4.3×-0.4×

Personalis, Inc.PSNL

9.8×+6.5×

NeoGenomicsNEO

1.2×-0.2×

Fulgent Genetics, Inc.FLGT

1.5×-0.1×

GeneDx HoldingsWGS

4.3×-3.1×

Other financials

Income statement

See full

Revenue$83.7M-4.9%

Gross profit$63.1M-11.8%

Operating income-$18.4M+34.1%

Net income-$14.5M+43.8%

EPS (diluted)-$0.49+45.6%

Balance sheet

See full

Cash & equivalents$63.8M-28.9%

Total debt$36.7M+42.1%

Total equity$461.4M+4.8%

Total assets$547.8M+9.2%

Cash flow

See full

Operating cash flow-$22.1M-267%

CapEx$12.5M+163%

Free cash flow-$34.6M-221%

Valuation

See full

Market cap$694.86M+29.9%

Enterprise value$667.82M+41.8%

P/S2×+0.5×

Profitability

See full

Gross margin77.9%-4.1pp

Operating margin-9.8%-30.8pp

Net margin-3.8%-10.2pp

FCF margin1.3%-10.7pp

Returns & leverage

See full

Return on equity-2.8%-10.6pp

Debt / equity0.1×0.0×

Current ratio6.7×-2.6×

Where this comes from

Calculated from Castle Biosciences’s reported figures.

enterprise value/total revenue=2.1×

Based on the most recent quarter.

The official record: Castle Biosciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Castle Biosciences's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Castle Biosciences's EV / sales?: Castle Biosciences (CSTL) reported EV / sales of 2.1× in Q1 2026.
How has Castle Biosciences's EV / sales changed year-over-year?: Castle Biosciences's EV / sales increased by 41.5% year-over-year, from 1.5× to 2.1×.
What is the long-term trend for Castle Biosciences's EV / sales?: Over 4 years (2021 to 2025), Castle Biosciences's EV / sales has grown at a -21.6% compound annual growth rate (CAGR), from 8.1× to 3.1×.
What does EV / sales mean?: Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.